{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:51:34Z","timestamp":1772164294541,"version":"3.50.1"},"reference-count":24,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several recent articles have reported the presence of a gammaretrovirus, termed \u201cXMRV\u201d (xenotropic murine leukemia virus-related virus) in prostate cancers (PCa). If confirmed, this could have enormous implications for the detection, prevention, and treatment of PCa. However, other articles report failure to detect XMRV in PCa. We tested nearly 800 PCa samples, using a combination of real-time PCR and immunohistochemistry (IHC). The PCR reactions were simultaneously monitored for amplification of a single-copy human gene, to confirm the quality of the sample DNA and its suitability for PCR. Controls showed that the PCR assay could detect the XMRV in a single infected cell, even in the presence of a 10,000-fold excess of uninfected human cells. The IHC used 2 rabbit polyclonal antisera, each prepared against a purified murine leukemia virus (MLV) protein. Both antisera always stained XMRV-infected or -transfected cells, but never stained control cells. No evidence for XMRV in PCa was obtained in these experiments. We discuss possible explanations for the discrepancies in the results from different laboratories. It is possible that XMRV is not actually circulating in the human population; even if it is, the data do not seem to support a causal role for this virus in PCa. Cancer Res; 70(24); 10028\u201333. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-2837","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T00:55:21Z","timestamp":1287708921000},"page":"10028-10033","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["XMRV: A New Virus in Prostate Cancer?"],"prefix":"10.1158","volume":"70","author":[{"given":"Amanda L.","family":"Aloia","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Sfanos","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"},{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"},{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qizhi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"},{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Maldarelli","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo M.","family":"De Marzo","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"},{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"},{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"},{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Rein","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland; Departments of 2Pathology, 3Urology, and 4Oncology, The Brady Urological Research Institute and 5The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"2022061702423472900_bib1","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.ppat.0020025","article-title":"Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant","volume":"2","author":"Urisman","year":"2006","journal-title":"PLoS Pathog"},{"key":"2022061702423472900_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.1179052","article-title":"Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome","volume":"326","author":"Lombardi","year":"2009","journal-title":"Science"},{"key":"2022061702423472900_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrurol.2010.77","article-title":"The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome","volume":"7","author":"Silverman","year":"2010","journal-title":"Nat Rev Urol"},{"key":"2022061702423472900_bib4","doi-asserted-by":"crossref","first-page":"16351","DOI":"10.1073\/pnas.0906922106","article-title":"XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors","volume":"106","author":"Schlaberg","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061702423472900_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.urology.2010.01.038","article-title":"XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH","volume":"75","author":"Arnold","year":"2010","journal-title":"Urology"},{"key":"2022061702423472900_bib6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1073\/pnas.0610291104","article-title":"An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors","volume":"104","author":"Dong","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061702423472900_bib7","doi-asserted-by":"crossref","first-page":"9964","DOI":"10.1128\/JVI.01299-08","article-title":"Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer","volume":"82","author":"Kim","year":"2008","journal-title":"J Virol"},{"key":"2022061702423472900_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcv.2008.04.016","article-title":"Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer","volume":"43","author":"Fischer","year":"2008","journal-title":"J Clin Virol"},{"key":"2022061702423472900_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-4690-6-92","article-title":"Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients","volume":"6","author":"Hohn","year":"2009","journal-title":"Retrovirology"},{"key":"2022061702423472900_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2407-10-326","article-title":"Identification of viral infections in the prostate and evaluation of their association with cancer","volume":"10","author":"Martinez-Fierro","year":"2010","journal-title":"BMC Cancer"},{"key":"2022061702423472900_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pros.20680","article-title":"A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms","volume":"68","author":"Sfanos","year":"2008","journal-title":"Prostate"},{"key":"2022061702423472900_bib12","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1128\/JVI.00546-09","article-title":"Multiple integrated copies and high-level production of the human retrovirus XMRV from 22Rv1 prostate carcinoma cells","volume":"83","author":"Knouf","year":"2009","journal-title":"J Virol"},{"key":"2022061702423472900_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/rmv.570","article-title":"Cellular proteins detected in HIV-1","volume":"18","author":"Ott","year":"2008","journal-title":"Rev Med Virol"},{"key":"2022061702423472900_bib14","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/jvi.69.5.3117-3124.1995","article-title":"Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus","volume":"69","author":"Arthur","year":"1995","journal-title":"J Virol"},{"key":"2022061702423472900_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/aid.1993.9.13","article-title":"Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus","volume":"9","author":"Cranage","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022061702423472900_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/266458a0","article-title":"Selective incorporation of H-2 antigenic determinants into Friend virus particles","volume":"266","author":"Bubbers","year":"1977","journal-title":"Nature"},{"key":"2022061702423472900_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1742-4690-7-57","article-title":"Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States","volume":"7","author":"Switzer","year":"2010","journal-title":"Retrovirology"},{"key":"2022061702423472900_bib18","doi-asserted-by":"crossref","first-page":"15874","DOI":"10.1073\/pnas.1006901107","article-title":"Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors","volume":"107","author":"Lo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061702423472900_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/MMBR.00033-07","article-title":"Human RNA \u201crumor\u201d viruses: the search for novel human retroviruses in chronic disease","volume":"72","author":"Voisset","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"key":"2022061702423472900_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1741-7007-8-124","article-title":"A cautionary tale of virus and disease","volume":"8","author":"Weiss","year":"2010","journal-title":"BMC Biol"},{"key":"2022061702423472900_bib21","first-page":"p. 475","article-title":"Retroviral pathogenesis","author":"Rosenberg","year":"1997"},{"key":"2022061702423472900_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"key":"2022061702423472900_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"2022061702423472900_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1357-2725(99)00074-6","article-title":"Deregulation of erythropoiesis by the Friend spleen focus-forming virus","volume":"31","author":"Ruscetti","year":"1999","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/24\/10028\/2641046\/10028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/24\/10028\/2641046\/10028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T06:31:40Z","timestamp":1655447500000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/24\/10028\/560294\/XMRV-A-New-Virus-in-Prostate-Cancer-Lack-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":24,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2010,12,14]]},"published-print":{"date-parts":[[2010,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-2837","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6502241.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6502241","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22388390","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22388390.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}